98 evolution "https:" "https:" "https:" "https:" "https:" "https:" "Bielefeld University •" uni jobs at Nature Careers in Germany
Sort by
Refine Your Search
-
We are seeking an experimental biologist to support the development of next-generation RNA-based precision therapies. The work is part of a core project within curATime (Cluster for Atherothrombosis
-
(RCB), the research focus “Ribonucleases” (https://go.ur.de/rna-biologie ) and the Regensburg Center of Ultrafast Nanoscopy (RUN) also provides a wide range of opportunities for collaboration. Active
-
at both institutions offers exceptional opportunities for the development of new research concepts. Your responsibilities As director of the NIhK, you will be responsible for managing the natural sciences
-
science. The program complements the MICROSTAR initiative, forming the HUMAN–MICROSTAR Alliance — a unified framework bridging host- and microbe-focused infection biology. More details: https
-
framework bridging host- and microbe-focused infection biology. More details: https://www.helmholtz-hzi.de/en/research/research-program/human-microstar/
-
with the IfSG before starting employment (currently: measles). General information on professorships, hiring processes, and the German academic system can be found here: https://uni-tuebingen.de/en
-
are able and willing to teach in both English and German are preferred. FAU offers career development, mentoring, and an attractive initial research budget. Based on international standards and transparent
-
. Qualified candidates are asked to apply via the Appointment Portal of the University of Bonn (https://berufungsportal.uni-bonn.de/openProcedureList.do ). The application can be submitted in German or English
-
application instructions) and to submit your application online, please visit: https://www.mpg.de/lise-meitner-excellence-program The deadline for applications is April 15, 2026. If you are invited to present
-
record in the development and application of innovative approaches for the preclinical and clinical advancement of cellular immunotherapies. A primary focus should be on the treatment of oncological